NASDAQ Companies

FARMINGTON HILLS, Mich., Feb. 05, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused […]

Approaching 6 anticipated data readouts across 3 platforms in 2024, including survival data in non-small cell lung cancer (NSCLC) and […]

MILTON, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, […]

—  Data served as foundation for current vaccine candidate for planned Phase 2 research —  Vaxart vaccine candidates elicited strong antigen-specific serum […]

MINNETONKA, Minn., Feb. 05, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ: PEGY) (“Pineapple” or the “Company”), a leading provider […]

Company is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when […]

YAVNE, Israel, Feb. 05, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation […]

NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B […]

– Financing led by TCGX with participation from new and existing investors including 5AM Ventures, Commodore Capital, Frazier Life Sciences, […]

— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial — — Company […]